{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:38:04Z","timestamp":1795019884853,"version":"4.10.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University | Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6\u22122018\u22120166"],"award-info":[{"award-number":["6\u22122018\u22120166"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes is highly prevalent in individuals with pancreatic ductal adenocarcinoma (PDAC) and even precedes diagnosis of PDAC; however, the mechanisms of pancreatic cancer-associated blood glucose deterioration remain largely unknown. Here, we constructed a prospective cohort of patients undergoing pancreatectomy to investigate the underlying mechanism of PDAC-associated hyperglycemia. A total of 160 patients who underwent pancreatectomy (72 patients with PDAC and 88 patients without PDAC) were enrolled at a tertiary care hospital. Glucometabolic parameters under oral glucose tolerance test were assessed in both pre- and postoperative periods, and patient-derived blood and pancreatic tissue samples were collected. Compared with patients without PDAC, patients with PDAC showed severe hyperglycemia with impaired insulin secretion before surgery. However, despite identical type of pancreatectomy in both groups, hyperglycemia improved more significantly and insulin secretory function declined less after pancreatectomy in patients with PDAC. Plasma Wnt5a and pancreatic islet \u03b2-catenin levels were higher in patients with PDAC and correlated with the degree of hyperglycemia and insulin deficiency. Plasma Wnt5a levels also correlated with tumor size and pancreatic islet \u03b2-catenin expression in patients with PDAC. In rodent islets, Wnt5a treatment suppressed insulin release, which was recovered by inhibition of \u03b2-catenin. Collectively, impaired pancreatic insulin secretion by aberrant Wnt5a\/\u03b2-catenin activation may underlie the hyperglycemia associated with PDAC. Our finding provides insights into the unique molecular mechanism of pancreatic cancer-associated hyperglycemia, paving the way for the identification of potential biomarker and therapeutic targets for this condition.<\/jats:p>","DOI":"10.1038\/s12276-025-01625-8","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:02:21Z","timestamp":1769569341000},"page":"272-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impaired insulin secretion via the Wnt5a\/\u03b2-catenin pathway contributes to diabetes development in pancreatic cancer"],"prefix":"10.1038","volume":"58","author":[{"given":"Minyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Seon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hae","family":"Nahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Woo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younhee","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0048-9112","authenticated-orcid":false,"given":"Dong Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Sup","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Seong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9719-4774","authenticated-orcid":false,"given":"Shinae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"1625_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12876-018-0866-z","volume":"18","author":"C Ntala","year":"2018","unstructured":"Ntala, C., Debernardi, S., Feakins, R. M. & Crnogorac-Jurcevic, T. Demographic, clinical, and pathological features of early onset pancreatic cancer patients. BMC Gastroenterol. 18, 139 (2018).","journal-title":"BMC Gastroenterol."},{"key":"1625_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.gastro.2018.04.025","volume":"155","author":"A Sharma","year":"2018","unstructured":"Sharma, A., Smyrk, T. C., Levy, M. J., Topazian, M. A. & Chari, S. T. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology 155, 490\u2013500 e492 (2018).","journal-title":"Gastroenterology"},{"key":"1625_CR3","first-page":"319","volume":"70","author":"E Molina-Montes","year":"2021","unstructured":"Molina-Montes, E. et al. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity\/BMI through causal inference and mediation analyses. Gut 70, 319\u2013329 (2021).","journal-title":"Gut"},{"key":"1625_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"DK Andersen","year":"2017","unstructured":"Andersen, D. K. et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 66, 1103\u20131110 (2017).","journal-title":"Diabetes"},{"key":"1625_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/MPA.0b013e3182a7c963","volume":"42","author":"PA Hart","year":"2013","unstructured":"Hart, P. A. & Chari, S. T. Diabetes mellitus and pancreatic cancer. Pancreas 42, 1207\u20131209 (2013).","journal-title":"Pancreas"},{"key":"1625_CR6","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi, A. D., Koay, E. J., Chari, S. T. & Maitra, A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology 156, 2024\u20132040 (2019).","journal-title":"Gastroenterology"},{"key":"1625_CR7","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142019 Abridged for primary care providers. Clin. Diabetes 37 11\u201334 (2019).","DOI":"10.2337\/cd18-0105"},{"key":"1625_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"key":"1625_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4093\/dmj.2023.0135","volume":"47","author":"ES Jin","year":"2023","unstructured":"Jin, E. S. et al. Dyslipidemia fact sheet in South Korea, 2022. Diabetes Metab. J. 47, 632\u2013642 (2023).","journal-title":"Diabetes Metab. J."},{"key":"1625_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"1625_CR11","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462\u20131470 (1999).","journal-title":"Diabetes Care"},{"key":"1625_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll, M. et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295\u2013301 (2000).","journal-title":"Diabetes Care"},{"key":"1625_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4093\/dmj.2018.0086","volume":"43","author":"TJ Oh","year":"2019","unstructured":"Oh, T. J. et al. Oral glucose tolerance testing allows better prediction of diabetes in women with a history of gestational diabetes mellitus. Diabetes Metab. J. 43, 342\u2013349 (2019).","journal-title":"Diabetes Metab. J."},{"key":"1625_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2337\/db10-1492","volume":"61","author":"S Kang","year":"2012","unstructured":"Kang, S. et al. Endothelial progenitor cell cotransplantation enhances islet engraftment by rapid revascularization. Diabetes 61, 866\u2013876 (2012).","journal-title":"Diabetes"},{"key":"1625_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccr.2009.07.016","volume":"16","author":"H Pei","year":"2009","unstructured":"Pei, H. et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259\u2013266 (2009).","journal-title":"Cancer Cell"},{"key":"1625_CR16","doi-asserted-by":"publisher","first-page":"e11499","DOI":"10.1371\/journal.pone.0011499","volume":"5","author":"L Marselli","year":"2010","unstructured":"Marselli, L. et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS ONE 5, e11499 (2010).","journal-title":"PLoS ONE"},{"key":"1625_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0083-6729(08)00619-5","volume":"80","author":"M Bordonaro","year":"2009","unstructured":"Bordonaro, M. Role of Wnt signaling in the development of type 2 diabetes. Vitam. Horm. 80, 563\u2013581 (2009).","journal-title":"Vitam. Horm."},{"key":"1625_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.molcel.2012.11.022","volume":"49","author":"A Chocarro-Calvo","year":"2013","unstructured":"Chocarro-Calvo, A., Garc\u00eda-Mart\u00ednez, J. oseM., Ardila-Gonz\u00e1lez, S., De la Vieja, A. & Garc\u00eda-Jim\u00e9nez, C. Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer. Mol. Cell 49, 474\u2013486 (2013).","journal-title":"Mol. Cell"},{"key":"1625_CR19","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JME-13-0152","volume":"52","author":"C Garcia-Jimenez","year":"2014","unstructured":"Garcia-Jimenez, C., Garcia-Martinez, J. M., Chocarro-Calvo, A. & De la Vieja, A. A new link between diabetes and cancer: enhanced WNT\/\u03b2-catenin signaling by high glucose. J. Mol. Endocrinol. 52, R51\u2013R66 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"1625_CR20","doi-asserted-by":"publisher","first-page":"728763","DOI":"10.1155\/2008\/728763","volume":"2008","author":"SH Lee","year":"2008","unstructured":"Lee, S. H. et al. Islet specific Wnt activation in human type II diabetes. Exp. Diabetes Res. 2008, 728763 (2008).","journal-title":"Exp. Diabetes Res."},{"key":"1625_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1593\/neo.05607","volume":"8","author":"G Zeng","year":"2006","unstructured":"Zeng, G. et al. Aberrant Wnt\/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8, 279\u2013289 (2006).","journal-title":"Neoplasia"},{"key":"1625_CR22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3892\/mmr.2015.4642","volume":"13","author":"H Bo","year":"2016","unstructured":"Bo, H., Gao, L., Chen, Y., Zhang, J. & Zhu, M. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model. Mol. Med. Rep. 13, 1163\u20131171 (2016).","journal-title":"Mol. Med. Rep."},{"key":"1625_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1593\/neo.121312","volume":"15","author":"H Griesmann","year":"2013","unstructured":"Griesmann, H. et al. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Neoplasia 15, 11\u201322 (2013).","journal-title":"Neoplasia"},{"key":"1625_CR24","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1210\/jc.2018-01007","volume":"103","author":"I Relling","year":"2018","unstructured":"Relling, I. et al. Role of wnt5a in metabolic inflammation in humans. J. Clin. Endocrinol. Metab. 103, 4253\u20134264 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1625_CR25","doi-asserted-by":"crossref","unstructured":"Kim, J. et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Sci. Transl. Med. 9, eaah5583 (2017).","DOI":"10.1126\/scitranslmed.aah5583"},{"key":"1625_CR26","doi-asserted-by":"publisher","first-page":"9863","DOI":"10.1074\/jbc.M114.606756","volume":"290","author":"SW Choi","year":"2015","unstructured":"Choi, S. W., Song, J. K., Yim, Y. S., Yun, H. G. & Chun, K. H. Glucose deprivation triggers protein kinase C-dependent \u03b2-catenin proteasomal degradation. J. Biol. Chem. 290, 9863\u20139873 (2015).","journal-title":"J. Biol. Chem."},{"key":"1625_CR27","doi-asserted-by":"crossref","unstructured":"Chen, Y. F., Chen, Z. X., Tang, Y. & Xiao, Q. The involvement of noncanonical Wnt signaling in cancers. Biomed. Pharmacother. 133, 110946 (2021).","DOI":"10.1016\/j.biopha.2020.110946"},{"key":"1625_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3892\/mmr.2015.3412","volume":"12","author":"P He","year":"2015","unstructured":"He, P. et al. Trophoblast glycoprotein promotes pancreatic ductal adenocarcinoma cell metastasis through Wnt\/planar cell polarity signaling. Mol. Med. Rep. 12, 503\u2013509 (2015).","journal-title":"Mol. Med. Rep."},{"key":"1625_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/cas.12080","volume":"104","author":"R Takahashi","year":"2013","unstructured":"Takahashi, R. et al. Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Cancer Sci. 104, 337\u2013344 (2013).","journal-title":"Cancer Sci."},{"key":"1625_CR30","doi-asserted-by":"crossref","unstructured":"Chmielowiec, J. et al. Human pancreatic microenvironment promotes \u03b2-cell differentiation via non-canonical WNT5A\/JNK and BMP signaling. Nat. Commun. 13, 1952 (2022).","DOI":"10.1038\/s41467-022-29646-1"},{"key":"1625_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cmet.2012.10.009","volume":"16","author":"T Mahdi","year":"2012","unstructured":"Mahdi, T. et al. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab. 16, 625\u2013633 (2012).","journal-title":"Cell Metab."},{"key":"1625_CR32","doi-asserted-by":"crossref","unstructured":"Yadav, R. & Patel, B. Insights on effects of Wnt pathway modulation on insulin signaling and glucose homeostasis for the treatment of type 2 diabetes mellitus: Wnt activation or Wnt inhibition? Int. J. Biol. Macromol. 261, 129634 (2024).","DOI":"10.1016\/j.ijbiomac.2024.129634"},{"key":"1625_CR33","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/anie.200462552","volume":"44","author":"J Liu","year":"2005","unstructured":"Liu, J. et al. A small-molecule agonist of the wnt signaling pathway. Angew. Chem. Int. Ed. 44, 1987\u20131990 (2005).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1625_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yexcr.2017.05.009","volume":"357","author":"SD Ahadome","year":"2017","unstructured":"Ahadome, S. D., Zhang, C., Tannous, E., Shen, J. & Zheng, J. J. Small-molecule inhibition of Wnt signaling abrogates dexamethasone-induced phenotype of primary human trabecular meshwork cells. Exp. Cell Res. 357, 116\u2013123 (2017).","journal-title":"Exp. Cell Res."},{"key":"1625_CR35","doi-asserted-by":"crossref","unstructured":"Dissanayake, W. C., Sorrenson, B. & Shepherd, P. R. The role of adherens junction proteins in the regulation of insulin secretion. Biosci. Rep. 38, BSR20170989 (2018).","DOI":"10.1042\/BSR20170989"},{"key":"1625_CR36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson, W. J. & Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483\u20131487 (2004).","journal-title":"Science"},{"key":"1625_CR37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/carcin\/bgl255","volume":"28","author":"S Ripka","year":"2007","unstructured":"Ripka, S. et al. WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28, 1178\u20131187 (2007).","journal-title":"Carcinogenesis"},{"key":"1625_CR38","doi-asserted-by":"crossref","unstructured":"Li, Y. J., Wei, Z. M., Meng, Y. X. & Ji, X. R. \u03b2-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: Relationships with carcinogenesis and metastasis. World J. Gastroenterol. 11, 2117\u20132123 (2005).","DOI":"10.3748\/wjg.v11.i14.2117"},{"key":"1625_CR39","doi-asserted-by":"crossref","unstructured":"Sommariva, M. & Gagliano, N. E-cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during EMT. Cells 9, 1040 (2020).","DOI":"10.3390\/cells9041040"},{"key":"1625_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","volume":"24","author":"\u00c5 Segerstolpe","year":"2016","unstructured":"Segerstolpe, \u00c5 et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 24, 593\u2013607 (2016).","journal-title":"Cell Metab."},{"key":"1625_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","volume":"10","author":"RP Sah","year":"2013","unstructured":"Sah, R. P., Nagpal, S. J., Mukhopadhyay, D. & Chari, S. T. New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat. Rev. Gastroenterol. Hepatol. 10, 423\u2013433 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1625_CR42","first-page":"2585","volume":"15","author":"D Basso","year":"1995","unstructured":"Basso, D. et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res. 15, 2585\u20132588 (1995).","journal-title":"Anticancer Res."},{"key":"1625_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/jsre.1998.5393","volume":"79","author":"F Wang","year":"1998","unstructured":"Wang, F., Larsson, J., Adrian, T. E., Gasslander, T. & Permert, J. In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J. Surg. Res. 79, 13\u201319 (1998).","journal-title":"J. Surg. Res."},{"key":"1625_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000085276","volume":"5","author":"ST Chari","year":"2005","unstructured":"Chari, S. T., Zapiach, M., Yadav, D. & Rizza, R. A. Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology 5, 229\u2013233 (2005).","journal-title":"Pancreatology"},{"key":"1625_CR45","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1111\/jcmm.16663","volume":"25","author":"X Nie","year":"2021","unstructured":"Nie, X., Wei, X., Ma, H., Fan, L. & Chen, W. D. The complex role of Wnt ligands in type 2 diabetes mellitus and related complications. J. Cell Mol. Med. 25, 6479\u20136495 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"1625_CR46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4093\/dmj.2018.0066","volume":"43","author":"YE Kang","year":"2019","unstructured":"Kang, Y. E. et al. Serum R-Spondin 1 is a new surrogate marker for obesity and insulin resistance. Diabetes Metab. J. 43, 368\u2013376 (2019).","journal-title":"Diabetes Metab. J."},{"key":"1625_CR47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999 (2017).","journal-title":"Cell"},{"key":"1625_CR48","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00125-012-2824-6","volume":"56","author":"N Wakae-Takada","year":"2013","unstructured":"Wakae-Takada, N., Xuan, S., Watanabe, K., Meda, P. & Leibel, R. L. Molecular basis for the regulation of islet beta cell mass in mice: the role of E-cadherin. Diabetologia 56, 856\u2013866 (2013).","journal-title":"Diabetologia"},{"key":"1625_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.14701\/ahbps.2020.24.3.269","volume":"24","author":"YJ Kim","year":"2020","unstructured":"Kim, Y. J. et al. Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus. Ann. Hepatobiliary Pancreat. Surg. 24, 269\u2013276 (2020).","journal-title":"Ann. Hepatobiliary Pancreat. Surg."},{"key":"1625_CR50","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4093\/dmj.2022.0205","volume":"47","author":"JS Lee","year":"2023","unstructured":"Lee, J. S., Sohn, M., Kim, K., Yoon, Y. S. & Lim, S. Glucose regulation after partial pancreatectomy: a comparison of pancreaticoduodenectomy and distal pancreatectomy in the short and long term. Diabetes Metab. J. 47, 703\u2013714 (2023).","journal-title":"Diabetes Metab. J."},{"key":"1625_CR51","doi-asserted-by":"crossref","unstructured":"Chikhladze, S. et al. Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data. World J. Surg. Oncol. 17, 185 (2019).","DOI":"10.1186\/s12957-019-1732-3"},{"key":"1625_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.hpb.2019.07.008","volume":"22","author":"DK DePeralta","year":"2020","unstructured":"DePeralta, D. K. et al. Completion of adjuvant therapy in patients with resected pancreatic cancer. HPB 22, 241\u2013248 (2020).","journal-title":"HPB"},{"key":"1625_CR53","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.3748\/wjg.v21.i19.5794","volume":"21","author":"CM Kang","year":"2015","unstructured":"Kang, C. M. & Lee, J. H. Pathophysiology after pancreaticoduodenectomy. World J. Gastroenterol. 21, 5794\u20135804 (2015).","journal-title":"World J. Gastroenterol."},{"key":"1625_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1365-182X(17)30622-6","volume":"1","author":"SW Kim","year":"1999","unstructured":"Kim, S. W., Kim, K. H., Han, J. K. & Park, Y. H. Pylorus-preservation decreases the extent of atrophy of the remnant pancreas after pancreatoduodenectomy. HPB 1, 65\u201370 (1999).","journal-title":"HPB"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01625-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:16:28Z","timestamp":1774419388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01625-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1625"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01625-8","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L. has received lecture honoraria from JW Pharmaceutical Corporation, Boryung Corporation, Eli Lilly and Company, Merck Sharp & Dohme, HK inno.N, Servier Korea, Handok Inc., Daewoong Pharmaceutical, Kukje Pharm Co., Ltd., GC Biopharma Corporation, Jeil Pharmaceutical Co., Ltd., and Boehringer Ingelheim. All other authors have no conflicts to disclose and no other relationships or activities that could appear to have influenced the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}